Live from the NIH registry
Studies recruiting near Port St. Lucie right now
Top 25 of 106 recruiting studies, sorted by proximity — each links to its official registry page
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: SWOG Cancer Research Network
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
CDC Research Institute — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Philip Morris Products S.A.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
East Florida Eye Institute — Stuart, Florida (10.1 mi)
· Sponsor: Boehringer Ingelheim
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Liver Fibrosis, Hepatic Cirrhosis
Phase 2
Interventional 104 participants sought
Research Site — Jupiter, Florida (29.9 mi)
· Sponsor: AstraZeneca
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Palm Beach Rheumatology and Wellness — Jupiter, Florida (29.9 mi)
· Sponsor: University of Alabama at Birmingham
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Epithelial Ovarian Cancer
Phase 3
Interventional 1,100 participants sought
Research Site — Jupiter, Florida (29.9 mi)
· Sponsor: AstraZeneca
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Pfizer
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
New Vision Eye Center /ID# 269955 — Vero Beach, Florida (24.8 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Alzheimer's Research and Treatment Center — Stuart, Florida (10.1 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Jupiter Research — Jupiter, Florida (29.9 mi)
· Sponsor: Janssen Research & Development, LLC
First-in-human Study of 7MW4911 in GI Cancer
GI Cancers
Phase 1, Phase 2
Interventional 200 participants sought
Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Jupiter, Florida (29.9 mi)
· Sponsor: 89bio, Inc.
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center — Stuart, Florida (10.1 mi)
· Sponsor: Hoffmann-La Roche
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1021 — Jupiter, Florida (29.9 mi)
· Sponsor: Immunovant Sciences GmbH
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
CDC Research Institute — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Regeneron Pharmaceuticals
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: BeOne Medicines
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Stuart, Florida (10.1 mi)
· Sponsor: AstraZeneca
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Phase 2
Interventional 175 participants sought
Midway Immunology and Research Center — Ft. Pierce, Florida (12.2 mi)
· Sponsor: Gilead Sciences
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 84 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Respiratory Syncytial Virus Infections
Phase 2
Interventional 192 participants sought
CDC Research Institute, LLC — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Shionogi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Phase 3
Interventional 400 participants sought
Vero Beach Neurology — Vero Beach, Florida (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Florida Cancer Specialists — Stuart, Florida (10.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
HIV Infections
Phase 3
Interventional 564 participants sought
GSK Investigational Site — Ft. Pierce, Florida (12.2 mi)
· Sponsor: ViiV Healthcare